PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2010 | 82 | 10 | 584-590
Tytuł artykułu

Optimal Curative Treatment For Early-Stage Hepatocellular Carcinoma: Hepatectomy Or Radiofrequency Ablation

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Słowa kluczowe
Wydawca

Rocznik
Tom
82
Numer
10
Strony
584-590
Opis fizyczny
Daty
wydano
2010-10-01
online
2010-12-06
Twórcy
  • Department of General Surgery, Hokkaido University Graduate School of Medicine, Japan
autor
  • Department of General Surgery, Hokkaido University Graduate School of Medicine, Japan
Bibliografia
  • Fan ST, Cheung ST, Lo CM: Indications for liver transplantation in patients with chronic hepatitis B and C virus infection and hepatocellular carcinoma. J Gastroenterol Hepatol 2000; 15 Suppl: E181-86.[Crossref]
  • Bismuth H, Majno PE, Adam R: Liver Transplantation for hepatocellular carcinoma. Semin Liver Dis 1999; 19: 311-22.[PubMed][Crossref]
  • Llovet JM, Fuster J, Bruix J: Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-40.[Crossref][PubMed]
  • Margarit C, Escartín A, Castells L et al.: Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl 2005; 11: 1242-51.[Crossref]
  • Poon RT, Fan ST, Lo CM et al.: Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002; 235: 373-82.
  • Belghiti J, Cortes A, Abdalla EK et al.: Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003; 238: 885-92; discussion 892-93.
  • Kamiyama T, Nakanishi K, Yokoo H et al.: Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of milan criteria utilization. Ann Surg Oncol 2009; 16: 1560-71.[PubMed][Crossref]
  • Orlando A, Leandro G, Olivo M et al.: Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol 2009; 104: 514-24.
  • Rossi S, Di Stasi M, Buscarini E et al.: Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996; 167: 759-68.
  • Curley SA, Izzo F, Delrio P et al.: Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230: 1-8.
  • Bowles BJ, Machi J, Limm WM et al.: Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001; 136: 864-69.
  • Lam VW, Ng KK, Chok KS et al.: Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg 2008; 207: 20-9.
  • Tateishi R, Shiina S, Teratani T et al.: Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103: 1201-09.
  • Livraghi T, Giorgio A, Marin G et al.: Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101-08.
  • Horigome H, Nomura T, Saso K et al.: Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence. Am J Gastroenterol 1999; 94: 1914-17.[Crossref][PubMed]
  • Harrison LE, Koneru B, Baramipour P et al.: Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J am coll Surg 2003; 197: 759-64.
  • Teratani T, Yoshida H, Shiina S et al.: Radio-frequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 2006; 43: 1101-08.[Crossref]
  • Bleicher RJ, Allegra DP, Nora DT et al.: Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003; 10: 52-58.[PubMed][Crossref]
  • Komorizono Y, Oketani M, Sako K et al.: Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003; 97: 1253-62.[PubMed][Crossref]
  • Lu DS, Raman SS, Limanond P et al.: Influence of large peritumoral vessels on outcome of radio-frequency ablation of liver tumors. J Vasc Interv Radiol 2003; 14: 1267-74.[Crossref]
  • Kim YS, Rhim H, Cho OK et al.: Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol 2006; 59: 432-41.[Crossref][PubMed]
  • Okuwaki Y, Nakazawa T, Shibuya A et al.: Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns. J Gastroenterol 2008; 43: 71-78.
  • Lin SM, Lin CJ, Lin CC et al.: Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004; 127: 1714-23.
  • Obara K, Matsumoto N, Okamoto M et al.: Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma. Hepatol Int 2008; 2: 116-23.[PubMed][Crossref]
  • Ruzzenente A, Manzoni GD, Molfetta M et al.: Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation. World J Gastroenterol 2004; 10: 1137-40.[PubMed]
  • Takada Y, Kurata M, Ohkohchi N: Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma. Int J Clin Oncol 2003; 8: 332-35.[PubMed][Crossref]
  • Llovet JM, Vilana R, Brú C et al.: Barcelona Clínic Liver Cancer (BCLC) Group. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33: 1124-29.[PubMed][Crossref]
  • Poon RT, Ng KK, Lam CM et al.: Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol 2004; 11: 281-89.[PubMed][Crossref]
  • Livraghi T, Lazzaroni S, Meloni F et al.: Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2005; 92: 856-58.
  • Imamura J, Tateishi R, Shiina S et al.: Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol 2008; 103: 3057-62.
  • Wong LL, Tanaka K, Lau L et al.: Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers. Clin Transplant 2004; 18: 227-34.[PubMed][Crossref]
  • Brillet PY, Paradis V, Brancatelli G et al.: Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison. AJR Am J Roentgenol 2006; 186(5 Suppl): S296-305.
  • Rodríguez-Sanjuán JC, González F, Juanco C et al.: Radiological and pathological assessment of hepatocellular carcinoma response to radiofrequency. A study on removed liver after transplantation. World J Surg 2008; 32: 1489-94.[Crossref]
  • Kasugai H, Osaki Y, Oka H et al.: Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients. Oncology: 2007; 72 Suppl 1: 72-75.
  • Arii S, Yamaoka Y, Futagawa S et al.: Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32: 1224-29.[Crossref]
  • Poon RT, Fan ST, Ng IO et al.: Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg 2000; 231: 544-51.
  • Majno PE, Sarasin FP, Mentha G et al.: Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 2000; 31: 899-906.[PubMed][Crossref]
  • Hasegawa K, Kokudo N, Imamura H et al.: Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005; 242: 252-59.
  • Makuuchi M, Hasegawa H, Yamazaki S: Ultra-sonically guided subsegmentectomy. Surg Gynecol Obstet 1985; 161: 346-50.
  • Eguchi S, Kanematsu T, Arii S et al.: Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 2008; 143: 469-75.
  • Yamashita Y, Taketomi A, Itoh S et al.: Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg 2007; 205: 19-26.
  • Imamura H, Matsuyama Y, Tanaka E et al.: Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38: 200-07.[Crossref][PubMed]
  • Kamiyama T, Nakanishi K, Yokoo H et al.: The impact of anatomical resection for hepatocellular carcinoma that meets the Milan criteria. J Surg Oncol 2010; 101: 54-60.[Crossref][PubMed]
  • Ikai I, Arii S, Ichida T et al.: Report of the 16th follow-up survey of primary liver cancer. Hepatol Res 2005; 32: 163-72.
  • Tobe T: Hepatectomy in patients with cirrhotic liver: clinical and basic observation. Surg Annu 1984; 121: 515-21.
  • Moser MA, Kneteman NM et al.: Research toward safer resection of the cirrhotic liver. HPB Surg 2000; 11: 285-97.[PubMed][Crossref]
  • Yamanaka N, Okamoto E, Oriyama T et al.: A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 1994; 219: 342-46.
  • Makuuchi M, Kosuge T, Takayama T et al.: Surgery for small liver cancers. Semin Surg oncol 1993; 9: 298-304.[Crossref][PubMed]
  • Nimura Y: Extended surgery in bilio-pancreatic cancer: the Japanese experience. Semin Oncol 2002; 29: 17-22.[PubMed]
  • Todo S, Furukawa H: Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004; 240: 451-59.
  • Adam R, Bismuth H, Castaing D et al.: Repeat hepatectomy for colorectal liver metastases. Ann Surg 1997; 225: 51-60.
  • Hashikura Y, Ichida T, Umeshita K et al.: Donor complications associated with living donor liver transplantation in Japan. Transplantation 2009; 88: 110-14.
  • Surman OS, Hertl M: Liver donation: donor safety comes first. Lancet 2003; 362: 674-75.
  • Yanaga K, Kanematsu T, Takenaka K et al.: Intraperitoneal septic complications after hepatectomy. Ann Surg 1986; 203: 148-52.
  • Mangram AJ, Horan TC, Pearson ML et al.: Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999; 27: 97-132.[Crossref][PubMed]
  • Kamiyama T, Nakanishi K, Yokoo H et al.: Perioperative management for hepatic resection towards zero mortality and morbidity: Analysis of 793 consecutive cases in a single institution. J Am Coll Surg 2010 (in press)
  • Asiyanbola B, Chang D, Gleisner AL et al.: Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg 2008; 12: 842-51.[PubMed][Crossref]
  • Buell JF, Koffron AJ, Thomas MJ et al.: Laparoscopic liver resection. J Am Coll Surg 2005; 200: 472-80.
  • Kamiyama T, Kurauchi N, Nakagawa T et al.: Laparoscopic hepatectomy with the hook blade of ultrasonic coagulating shears and bipolar cautery with a saline irrigation system. J Hepatobiliary Pancreat Surg 2005; 12: 49-54.[Crossref]
  • Buell JF, Cherqui D, Geller DA et al.: The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg 2009; 250: 825-30.
  • Chen MS, Li JQ, Zheng Y et al.: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243: 321-28.
  • Lü MD, Kuang M, Liang LJ et al.: Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 2006; 86: 801-05.
  • Guglielmi A, Ruzzenente A, Valdegamberi A et al.: Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2008; 12: 192-98.[Crossref][PubMed]
  • Hong SN, Lee SY, Choi MS et al.: Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepato-cellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005; 39: 247-52.[Crossref]
  • Takayama T, Makuuchi M, Hasegawa K: Single HCC smaller than 2 cm: surgery or ablation? : Surgeon's perspective. J Hepatobiliary Pancreat Surg 2009 Nov 21. [Epub ahead of print]
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.-psjd-doi-10_2478_v10035-010-0088-8
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.